The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Pathogenesis of Candida albicans biofilm
Open accessAbstract
Candida albicans is the most common human fungal pathogen causing diseases ranging from mucosal to systemic infections. As a commensal, C. albicans asymptomatically colonizes mucosal surfaces; however, any disruption in the host environment or under conditions of immune dysfunction, C. albicans can proliferate and invade virtually any site in the host. The ability of this highly adaptable fungal species to transition from commensal to pathogen is due to a repertoire of virulence factors. Specifically, the ability to switch morphology and form biofilms are properties central to C. albicans pathogenesis. In fact, the majority of C. albicans infections are associated with biofilm formation on host or abiotic surfaces such as indwelling medical devices, which carry high morbidity and mortality. Significantly, biofilms formed by C. albicans are inherently tolerant to antimicrobial therapy and therefore, the susceptibility of Candida biofilms to the current therapeutic agents remains low. The aim of this review is to provide an overview of C. albicans highlighting some of the diverse biofilm-associated diseases caused by this opportunistic pathogen and the animal models available to study them. Further, the classes of antifungal agents used to combat these resilient infections are discussed along with mechanisms of drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“Candida albicans is the most common fungal human pathogen causing diseases ranging from superficial mucosal to lifethreatening systemic infections (Pfaller and Diekema 2007; Ganguly and Mitchell 2011; Calderone 2012).”
BackgroundBiofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 2×
“These cells termed ‘persister cells’ are not mutants and are often deeply embedded in the biofilm where they become dormant and therefore, unaffected by antimicrobial agents which target metabolically active cells (LaFleur, Kumamoto and Lewis 2006; Lewis 2007; Dawson, Intapa and Jabra-Rizk 2011).”
BackgroundLewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,785
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis
Naglik, J. R., Challacombe, S. J., & Hube, B. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.3.400-428.2003 · Cited by 1,179
Calderone, R. (2012) · ASM Press eBooks · Cited by 912
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Biofilm in Implant Infections: Its Production and Regulation
Costerton, J. W., Montanaro, L., & Arciola, C. R. (2005) · The International Journal of Artificial Organs · doi:10.1177/039139880502801103 · Cited by 804
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 764
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Perlroth, J., Choi, B., & Spellberg, B. (2007) · Medical Mycology · doi:10.1080/13693780701218689 · Cited by 738
Polymicrobial Interactions: Impact on Pathogenesis and Human Disease
Peters, B. M., Jabra-Rizk, M. A., O'May, G. A., Costerton, J. W., & Shirtliff, M. E. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-11 · Cited by 712
Self-citationA Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans
Nobile, C. J., Fox, E. P., Nett, J. E., Sorrells, T. R., Mitrovich, Q. M., Hernday, A. D., Tuch, B. B., Andes, D. R., & Johnson, A. D. (2012) · Cell · doi:10.1016/j.cell.2011.10.048 · Cited by 711
Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule
Ramage, G., Saville, S. P., Wickes, B. L., & López-Ribot, J. L. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5459-5463.2002 · Cited by 701
Ramage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678
Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells
Phan, Q. T., Myers, C. L., Fu, Y., Sheppard, D. C., Yeaman, M. R., Welch, W. H., Ibrahim, A. S., Edwards, J. E., & Filler, S. G. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050064 · Cited by 641
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Genetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 612
Efflux-Mediated Antifungal Drug Resistance
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., & Monk, B. C. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-08 · Cited by 608
Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality
Remijsen, Q., Kuijpers, T. W., Wirawan, E., Lippens, S., Vandenabeele, P., & Vanden Berghe, T. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.1 · Cited by 607
Candida albicans: A molecular revolution built on lessons from budding yeast
Berman, J., & Sudbery, P. E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg948 · Cited by 578
Al-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
The ALS gene family of Candida albicans.
Hoyer, L. L. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)01984-9 · Cited by 540
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Persister cells and the riddle of biofilm survival
Lewis, K. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0111-6 · Cited by 520
Mukherjee, P. K., Chandra, J., Kuhn, D. M., & Ghannoum, M. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4333-4340.2003 · Cited by 511 · cited 1×
“However, the expression of these efflux pump genes was found to decrease as the biofilm ages, contrary to existing patterns of mechanism of resistance in biofilms where expression of resistance genes increases as the biofilmmatures (Mukherjee et al. 2003).”
BackgroundRamage, G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf049 · Cited by 468
Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
Uppuluri, P., Chaturvedi, A. K., Srinivasan, A., Banerjee, M., Ramasubramaniam, A. K., Köhler, J. R., Kadosh, D., & Lopez-Ribot, J. L. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000828 · Cited by 432
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-06 · Cited by 407 · cited 1×
“In C. albicans, the biofilm matrix is largely composed of polysaccharides such as β-1,3-glucan, β-1,6-glucan, and mannans and to a lesser extent, proteins (Al-Fattani and Douglas 2006; Nett et al. 2007; Nett, Sanchez and Andes 2011; Zarnowski et al. 2014).”
BackgroundSanglard, D., Ischer, F., Monod, M., & Bille, J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2300 · Cited by 402
Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., & Pitula, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6023-6031.2004 · Cited by 389
Baillie, G. S. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.397 · Cited by 389
Candida albicans dimorphism as a therapeutic target
Jacobsen, I. D., Wilson, D., Wächtler, B., Brunke, S., Naglik, J. R., & Hube, B. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.152 · Cited by 363
Pathogenesis and treatment of oral candidosis
Williams, D., & Lewis, M. (2011) · Journal of Oral Microbiology · doi:10.3402/jom.v3i0.5771 · Cited by 356
Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351
Novel Entries in a Fungal Biofilm Matrix Encyclopedia
Zarnowski, R., Westler, W. M., Lacmbouh, G. A., Marita, J. M., Bothe, J. R., Bernhardt, J., Lounes-Hadj Sahraoui, A., Fontaine, J., Sanchez, H., Hatfield, R. D., et al. (2014) · mBio · doi:10.1128/mbio.01333-14 · Cited by 315
Candida albicans forms biofilms on the vaginal mucosa
Harriott, M. M., Lilly, E. A., Rodriguez, T. E., Fidel, P. L., & Noverr, M. C. (2010) · Microbiology · doi:10.1099/mic.0.039354-0 · Cited by 301 · cited 1×
“…properties of C. albicans have been proposed to play major roles in causing recurring VVC; notably, strains of C. albicans defective in hyphae formation display significantly reduced vaginitis symptomatology indicating a requirement for hyphae in the pathogenesis of disease (Harriott et al. 2010).”
BackgroundEchinocandins: a new class of antifungal
Denning, D. W. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf045 · Cited by 300
Fungal Biofilms and Drug Resistance
Jabra-Rizk, M. A., Falkler, W. A., & Meiller, T. F. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1001.030119 · Cited by 292
Self-citationA Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance
Taff, H. T., Nett, J. E., Zarnowski, R., Ross, K. M., Sanchez, H., Cain, M. T., Hamaker, J., Mitchell, A. P., & Andes, D. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002848 · Cited by 291
In Vitro Activity of Caspofungin against Candida albicans Biofilms
Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3591-3596.2002 · Cited by 288
Genetics and genomics of Candida albicans biofilm formation
Nobile, C. J., & Mitchell, A. P. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00761.x · Cited by 278
Candida albicans interactions with epithelial cells and mucosal immunity
Naglik, J. R., Moyes, D. L., Wächtler, B., & Hube, B. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.06.009 · Cited by 277
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
Genetic Basis of Candida Biofilm Resistance Due to Drug‐Sequestering Matrix Glucan
Nett, J. E., Sanchez, H., Cain, M. T., & Andes, D. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/651200 · Cited by 250
Martins, M., Uppuluri, P., Thomas, D. P., Cleary, I. A., Henriques, M., Lopez-Ribot, J. L., & Oliveira, R. (2010) · Mycopathologia · doi:10.1007/s11046-009-9264-y · Cited by 250
Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p
Peters, B. M., Ovchinnikova, E. S., Krom, B. P., Schlecht, L. M., Zhou, H., Hoyer, L. L., Busscher, H. J., van der Mei, H. C., Jabra-Rizk, M. A., & Shirtliff, M. E. (2012) · Microbiology · doi:10.1099/mic.0.062109-0 · Cited by 250
Self-citationCritical role of germ tube formation in the pathogenesis of candidal vaginitis
Sobel, J. D., Muller, G., & Buckley, H. R. (1984) · Infection and Immunity · doi:10.1128/iai.44.3.576-580.1984 · Cited by 242
Leidich, S. D., Ibrahim, A. S., Fu, Y., Koul, A., Jessup, C., Vitullo, J., Fonzi, W., Mirbod, F., Nakashima, S., Nozawa, Y., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26078 · Cited by 241
Effect of Growth Rate on Resistance of Candida albicans Biofilms to Antifungal Agents
Baillie, G. S., & Douglas, L. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1900 · Cited by 234
Farnesol-Induced Apoptosis in Candida albicans
Shirtliff, M. E., Krom, B. P., Meijering, R. A. M., Peters, B. M., Zhu, J., Scheper, M. A., Harris, M. L., & Jabra-Rizk, M. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01551-08 · Cited by 230
Self-citationSchaller, M., Korting, H. C., Schäfer, W., Bastert, J., Chen, W., & Hube, B. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01590.x · Cited by 228
MUKHERJEE, P., & CHANDRA, J. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.09.002 · Cited by 222
Nolte, F. S., Parkinson, T., Falconer, D. J., Dix, S., Williams, J., Gilmore, C., Geller, R., & Wingard, J. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.196 · Cited by 219
Candida albicans biofilm development, modeling a host–pathogen interaction
Nett, J., & Andes, D. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.007 · Cited by 210
Mannosylation in Candida albicans: role in cell wall function and immune recognition
Hall, R. A., & Gow, N. A. R. (2013) · Molecular Microbiology · doi:10.1111/mmi.12426 · Cited by 210
Candida albicans drug resistance—Another way to cope with stress
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., & Monk, B. C. (2007) · Microbiology · doi:10.1099/mic.0.2007/010405-0 · Cited by 208
Mouse model of oropharyngeal candidiasis
Solis, N. V., & Filler, S. G. (2012) · Nature Protocols · doi:10.1038/nprot.2012.011 · Cited by 208
Nett, J. E., Crawford, K., Marchillo, K., & Andes, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-10 · Cited by 207
Mucosal biofilms of Candida albicans
Ganguly, S., & Mitchell, A. P. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.06.001 · Cited by 200
Interactions of Candida albicans with host epithelial surfaces
Williams, D. W., Jordan, R. P. C., Wei, X., Alves, C. T., Wise, M. P., Wilson, M. J., & Lewis, M. A. O. (2013) · Journal of Oral Microbiology · doi:10.3402/jom.v5i0.22434 · Cited by 194
Community participation in biofilm matrix assembly and function
Mitchell, K. F., Zarnowski, R., Sanchez, H., Edward, J. A., Reinicke, E. L., Nett, J. E., Mitchell, A. P., & Andes, D. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421437112 · Cited by 183
Rabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy
Schinabeck, M. K., Long, L. A., Hossain, M. A., Chandra, J., Mukherjee, P. K., Mohamed, S., & Ghannoum, M. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1727-1732.2004 · Cited by 180
Redding, S. W., Zellars, R. C., Kirkpatrick, W. R., McAtee, R. K., Caceres, M. A., Fothergill, A. W., Lopez-Ribot, J. L., Bailey, C. W., Rinaldi, M. G., & Patterson, T. F. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.12.3896-3900.1999 · Cited by 174
Nett, J. E., Sanchez, H., Cain, M. T., Ross, K. M., & Andes, D. R. (2011) · Eukaryotic Cell · doi:10.1128/ec.05126-11 · Cited by 168
Innate immune mechanisms for recognition and uptake of Candida species
Netea, M. G., & Maródi, L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.06.007 · Cited by 168
Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms
Perumal, P., Mekala, S., & Chaffin, W. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01237-06 · Cited by 165
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00303-10 · Cited by 165
[48] Candida biofilms and their susceptibility to antifungal agents
Baillie, G. S., & Douglas, L. J. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)10050-8 · Cited by 161
Development and Validation of an In Vivo Candida albicans Biofilm Denture Model
Nett, J. E., Marchillo, K., Spiegel, C. A., & Andes, D. R. (2010) · Infection and Immunity · doi:10.1128/iai.00480-10 · Cited by 161
Nailis, H., Kucharíková, S., Řičicová, M., Van Dijck, P., Deforce, D., Nelis, H., & Coenye, T. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-114 · Cited by 157
Ramírez‐Amador, V., Silverman, S., Mayer, P., Tyler, M., & Quivey, J. M. (1997) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/s1079-2104(97)90061-5 · Cited by 154
Candida Vaginitis: When Opportunism Knocks, the Host Responds
Peters, B. M., Yano, J., Noverr, M. C., & Fidel, P. L. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003965 · Cited by 153
Meiller, T. F., Hube, B., Schild, L., Shirtliff, M. E., Scheper, M. A., Winkler, R., Ton, A., & Jabra‐Rizk, M. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005039 · Cited by 145
Self-citation“Persisters”: Survival at the Cellular Level
Dawson, C. C., Intapa, C., & Jabra‐Rizk, M. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002121 · Cited by 141
Self-citationSundstrom, P., Balish, E., & Allen, C. M. (2002) · The Journal of Infectious Diseases · doi:10.1086/338836 · Cited by 140
Murciano, C., Moyes, D. L., Runglall, M., Tobouti, P. L., Islam, A., Hoyer, L. L., & Naglik, J. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033362 · Cited by 133
Chandra, J., McCormick, T. S., Imamura, Y., Mukherjee, P. K., & Ghannoum, M. A. (2007) · Infection and Immunity · doi:10.1128/iai.01841-06 · Cited by 130
Lermann, U., & Morschhäuser, J. (2008) · Microbiology · doi:10.1099/mic.0.2008/022525-0 · Cited by 128
Echinocandins and pneumocandins--a new antifungal class with a novel mode of action
Denning, D. W. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.5.611 · Cited by 126
Chauvel, M., Nesseir, A., Cabral, V., Znaidi, S., Goyard, S., Bachellier‐Bassi, S., Firon, A., Legrand, M., Diogo, D., Naulleau, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045912 · Cited by 124
Candida -Host Interactions in HIV Disease: Implications for Oropharyngeal Candidiasis
Fidel, P. L. (2011) · Advances in Dental Research · doi:10.1177/0022034511399284 · Cited by 123
Candida -Host Interactions in HIV Disease: Relationships in Oropharyngeal Candidiasis
Fidel, P. L. (2006) · Advances in Dental Research · doi:10.1177/154407370601900116 · Cited by 123
Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole
Bink, A., Vandenbosch, D., Coenye, T., Nelis, H., Cammue, B. P. A., & Thevissen, K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00280-11 · Cited by 119
Yano, J., & Fidel, P. L. (2011) · Journal of Visualized Experiments · doi:10.3791/3382 · Cited by 118
Dynamic interactions of neutrophils and biofilms
Hirschfeld, J. (2014) · Journal of Oral Microbiology · doi:10.3402/jom.v6.26102 · Cited by 118
(2011) · ASM Press eBooks · doi:10.1128/9781555817176 · Cited by 118
Sundstrom, P., Cutler, J. E., & Staab, J. F. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3281-3283.2002 · Cited by 117
CandidaBiofilms and the Host: Models and New Concepts for Eradication
Tournu, H., & Dijck, P. V. (2011) · International Journal of Microbiology · doi:10.1155/2012/845352 · Cited by 115
Adherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole
Mateus, C., Crow, S. A., & Ahearn, D. G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3358-3366.2004 · Cited by 113
Candida albicans biofilm formation in a new in vivo rat model
Řičicová, M., Kucharíková, S., Tournu, H., Hendrix, J., Bujdáková, H., Eldere, J. V., Lagrou, K., & Dijck, P. V. (2009) · Microbiology · doi:10.1099/mic.0.033530-0 · Cited by 110
Theiß, S., Ishdorj, G., Brenot, A., Kretschmar, M., Lan, C., Nichterlein, T., Hacker, J. H., Nigam, S., Agabian, N. M., & Köhler, G. A. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.03.003 · Cited by 109
Cell Density and Cell Aging as Factors Modulating Antifungal Resistance ofCandida albicansBiofilms
Seneviratne, C. J., Jin, L., Samaranayake, Y. H., & Samaranayake, L. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00541-08 · Cited by 107
Echinocandins — An Advance in the Primary Treatment of Invasive Candidiasis
Walsh, T. J. (2002) · New England Journal of Medicine · doi:10.1056/nejme020142 · Cited by 105
Lazzell, A. L., Chaturvedi, A. K., Pierce, C. G., Prasad, D., Uppuluri, P., & Lopez-Ribot, J. L. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp242 · Cited by 105
Shuford, J. A., Rouse, M. S., Piper, K. E., Steckelberg, J. M., & Patel, R. (2006) · The Journal of Infectious Diseases · doi:10.1086/506452 · Cited by 101
Iron-Limited Biofilms of Candida albicans and Their Susceptibility to Amphotericin B
Baillie, G. S., & Douglas, L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2146 · Cited by 95
Zhu, J., Krom, B. P., Sanglard, D., Intapa, C., Dawson, C. C., Peters, B. M., Shirtliff, M. E., & Jabra‐Rizk, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028830 · Cited by 83
Self-citationFarnesol, a Fungal Quorum-Sensing Molecule Triggers Apoptosis in Human Oral Squamous Carcinoma Cells
Scheper, M. A., Shirtliff, M. E., Meiller, T. F., Peters, B. M., & Jabra‐Rizk, M. A. (2008) · Neoplasia · doi:10.1593/neo.08444 · Cited by 80
Self-citationCatching Fire: Candida albicans, Macrophages, and Pyroptosis
Krysan, D. J., Sutterwala, F. S., & Wellington, M. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004139 · Cited by 78
Kucharíková, S., Tournu, H., Holtappels, M., Dijck, P. V., & Lagrou, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00697-10 · Cited by 73
Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance
Niimi, M., Niimi, K., Takano, Y., Holmes, A. R., Fischer, F. J., Uehara, Y., & Cannon, R. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh456 · Cited by 69
Hawser, S. (1996) · Medical Mycology · doi:10.1080/02681219680000231 · Cited by 63
Ghannoum, M. A., Roilides, E., Katragkou, A., Petraitis, V., & Walsh, T. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ815 · Cited by 62
Fungal peritonitis in children on peritoneal dialysis
Raaijmakers, R., Schröder, C. H., Monnens, L. A. H., Cornelissen, E. A. M., & Warris, A. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0289-x · Cited by 51
Lepak, A. J., Nett, J. E., Lincoln, L., Marchillo, K., & Andes, D. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1311-1319.2006 · Cited by 48
Microbial cell surface proteins and secreted metabolites involved in multispecies biofilms
Demuyser, L., Jabra‐Rizk, M. A., & Dijck, P. V. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12123 · Cited by 43
Self-citationFabrication of a multi‐applicable removable intraoral denture system for rodent research
Lee, H. E., Yu, A., Johnson, C. C., Lilly, E. A., Noverr, M. C., & Fidel, P. L. (2011) · Journal of Oral Rehabilitation · doi:10.1111/j.1365-2842.2011.02206.x · Cited by 30
Pathogenesis of Polymicrobial Biofilms
Jabra‐Rizk, M. A. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010039 · Cited by 30
Self-citationThe Great Escape: Pathogen Versus Host
Kong, E. F., & Jabra‐Rizk, M. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004661 · Cited by 19
Self-citationFarnesol and Candida albicans: Quorum Sensing or Not Quorum Sensing?
Krom, B. P., Levy, N., Meijler, M. M., & Jabra‐Rizk, M. A. (2015) · Israel Journal of Chemistry · doi:10.1002/ijch.201500025 · Cited by 15
Self-citationPhysiological functions of multidrug transporters in yeast
Prasad, R., & Panwar, S. L. (2004) · Cited by 9
Cited by
The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species
Garcia-Rubio, R., de Oliveira, H. C., Rivera, J., & Trevijano-Contador, N. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02993 · Cited by 917
Candida albicans—The Virulence Factors and Clinical Manifestations of Infection
Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & Škrlec, I. (2021) · Journal of Fungi · doi:10.3390/jof7020079 · Cited by 794
“The transition from yeast to the hyphal form is a transition into a pathogenic form [22,23].”
BackgroundHorizontal Gene Transfer of Antibiotic Resistance Genes in Biofilms
Michaelis, C., & Grohmann, E. (2023) · Antibiotics · doi:10.3390/antibiotics12020328 · Cited by 612
Oral Candidiasis: A Disease of Opportunity
Vila, T., Sultan, A. S., Montelongo-Jauregui, D., & Jabra-Rizk, M. A. (2020) · Journal of Fungi · doi:10.3390/jof6010015 · Cited by 537
Self-citationLarkin, E., Hager, C., Chandra, J., Mukherjee, P. K., Retuerto, M., Salem, I., Long, L., Isham, N., Kovanda, L., Borroto-Esoda, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02396-16 · Cited by 395
Metadata
- Authors
- Tsui, C., Kong, E. F., & Jabra-Rizk, M. A.
- Venue
- Pathogens and Disease
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-09
- Volume
- 74
- Issue
- 4
- Pages
- ftw018
- ISSN
- 2049-632X (ISSN-L)
- OpenAlex
- W2295676242
- Cited by
- 481
- References
- 118
- FWCI
- 22.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.